Request Demo
Last update 10 Jun 2025
Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)
Last update 10 Jun 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)CTR20211597
在健康受试者中评价HS-20090-2注射液比对Prolia注射液在药代动力学、安全性和免疫原性上的随机、平行对照的I期临床研究
[Translation] A randomized, parallel-controlled phase I clinical study to evaluate the pharmacokinetics, safety, and immunogenicity of HS-20090-2 injection versus Prolia injection in healthy subjects
100 Clinical Results associated with Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)
Login to view more data
100 Deals associated with Recombinant aiti-RANKL human monoclonal antibody(Shanghai Hansoh Biomedical Co. Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoporosis, Postmenopausal | Phase 1 | China | 26 Jul 2021 | |
| Neoplasms | IND Application | China | 06 Jan 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free